The dinoflagellate-derived polyether prorocentin is a
co-metabolite
of the archetypical serine/threonine phosphatase inhibitor okadaic
acid. Whereas a structural relationship cannot be missed and a biosynthetic
link was proposed, it is currently unknown whether there is any parallel
in the bioactivity profile of these natural products. However, it
was insinuated in the past that the structure assigned to prorocentin
might need to be revised. Indeed, re-examination of the published
spectra cast doubts as to the constitution of the fused/spirotricyclic
BCD-ring system in the core. To clarify this issue, a flexible synthesis
blueprint was devised that allowed us to obtain the originally proposed
structure as well as the most plausible amended structure. The key
to success was late-stage gold-catalyzed spirocyclization reactions
that furnished the isomeric central segments with excellent selectivity.
The lexicon of catalytic transformations used to make the required
cyclization precursors comprised a titanium-mediated ester methylenation/metathesis
cascade, a rare example of a gold-catalyzed allylic substitution,
and chain extensions via organocatalytic asymmetric aldehyde propargylation.
A wing sector to be attached to the isomeric cores was obtained by
Krische allylation, followed by a superbly selective cobalt-catalyzed
oxidative cyclization of the resulting di-unsaturated alcohol with
the formation of a 2,5-trans-disubstituted tetrahydrofuran;
the remaining terminal alkene was elaborated into an appropriate handle
for fragment coupling by platinum-catalyzed asymmetric diboration/oxidation.
The assembly of the different building blocks to the envisaged isomeric
target compounds proved that the structure of prorocentin needs to
be revised as disclosed herein.